[go: up one dir, main page]

NO993948D0 - Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser - Google Patents

Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser

Info

Publication number
NO993948D0
NO993948D0 NO993948A NO993948A NO993948D0 NO 993948 D0 NO993948 D0 NO 993948D0 NO 993948 A NO993948 A NO 993948A NO 993948 A NO993948 A NO 993948A NO 993948 D0 NO993948 D0 NO 993948D0
Authority
NO
Norway
Prior art keywords
aryl
cns disorders
derivatives against
against cns
cyclohexylamine derivatives
Prior art date
Application number
NO993948A
Other languages
English (en)
Other versions
NO993948L (no
Inventor
Alexander Alanine
Bernd Buettelmann
Emmanuel Pinard
Rene Wyler
Marie-Paule Heitz Neidhart
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO993948D0 publication Critical patent/NO993948D0/no
Publication of NO993948L publication Critical patent/NO993948L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO993948A 1998-08-18 1999-08-17 Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser NO993948L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98115484 1998-08-18

Publications (2)

Publication Number Publication Date
NO993948D0 true NO993948D0 (no) 1999-08-17
NO993948L NO993948L (no) 2000-02-21

Family

ID=8232474

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993948A NO993948L (no) 1998-08-18 1999-08-17 Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser

Country Status (24)

Country Link
US (1) US6184236B1 (no)
JP (1) JP3455142B2 (no)
KR (1) KR100341194B1 (no)
CN (1) CN1141936C (no)
AR (1) AR021770A1 (no)
AT (1) ATE326219T1 (no)
AU (1) AU756408B2 (no)
BR (1) BR9903779A (no)
CA (1) CA2280455A1 (no)
DE (1) DE69931316D1 (no)
HR (1) HRP990256A2 (no)
HU (1) HUP9902737A3 (no)
ID (1) ID23107A (no)
IL (1) IL131399A0 (no)
MA (1) MA26677A1 (no)
MY (1) MY133133A (no)
NO (1) NO993948L (no)
NZ (1) NZ337243A (no)
PE (1) PE20000955A1 (no)
PL (1) PL334949A1 (no)
SG (1) SG82014A1 (no)
TR (1) TR199902015A2 (no)
YU (1) YU38699A (no)
ZA (1) ZA995212B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0111267A (pt) * 2000-06-06 2003-12-16 Warner Lambert Co Cicloexilaminas bicìclicas e seu uso como antagonistas do receptor de nmda
EP1436258A4 (en) * 2001-03-08 2005-03-23 Univ Emory PH VALVE DEPENDENT NMDA RECEPTOR ANTAGONISTS
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
US8420680B2 (en) * 2007-06-29 2013-04-16 Emory University NMDA receptor antagonists for neuroprotection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032766A1 (de) 1990-10-16 1992-04-30 Basf Ag Phenylpiperidinoylamine und diese enthaltende arzneimittel
DE4117904A1 (de) 1991-05-31 1992-12-03 Basf Ag Substituierte n-phenylpiperidine
EP0503411B1 (de) 1991-03-14 1995-11-29 BASF Aktiengesellschaft Substituierte N-Phenylpiperidine und Arzneimittel daraus
EP0940387B1 (en) 1995-10-26 2003-05-07 Mitsubishi Pharma Corporation Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same

Also Published As

Publication number Publication date
JP3455142B2 (ja) 2003-10-14
YU38699A (sh) 2002-03-18
AU4453799A (en) 2000-05-04
NZ337243A (en) 2000-12-22
AR021770A1 (es) 2002-08-07
DE69931316D1 (de) 2006-06-22
ATE326219T1 (de) 2006-06-15
IL131399A0 (en) 2001-01-28
ZA995212B (en) 2000-02-18
PE20000955A1 (es) 2000-09-28
JP2000109429A (ja) 2000-04-18
US6184236B1 (en) 2001-02-06
ID23107A (id) 2000-02-24
AU756408B2 (en) 2003-01-09
NO993948L (no) 2000-02-21
PL334949A1 (en) 2000-02-28
MA26677A1 (fr) 2004-12-20
CA2280455A1 (en) 2000-02-18
HU9902737D0 (en) 1999-10-28
KR100341194B1 (ko) 2002-06-20
CN1141936C (zh) 2004-03-17
HUP9902737A2 (hu) 2000-06-28
HRP990256A2 (en) 2000-04-30
KR20000017343A (ko) 2000-03-25
MY133133A (en) 2007-10-31
BR9903779A (pt) 2000-09-19
HUP9902737A3 (en) 2001-01-29
TR199902015A3 (tr) 2000-03-21
TR199902015A2 (xx) 2000-03-21
SG82014A1 (en) 2001-07-24
CN1248439A (zh) 2000-03-29

Similar Documents

Publication Publication Date Title
NO20012995L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
ATE245158T1 (de) Bicyclische hydroxamsäurederivate
FI963761L (fi) Kefalosporiinin synteesi
NO20011083L (no) Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
NO20001387L (no) FremgangsmÕte for syntese av kinolinderivater
DK1224163T3 (da) Anvendelse af carbonylaminoderivater mod CNS-lidelser
NO993948D0 (no) Anvendelse av aryl-cykloheksylamin-derivater mot CNS-forstyrrelser
NO20026005L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20011892L (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20030127L (no) Indolderivater nyttige for behandling av CNS-forstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20026029L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
ATE243218T1 (de) 2''-deoxyhygromycinderivate
NO20026028L (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina
FI953860A0 (fi) Yhdistelmäpalkki
FI980433A0 (fi) Foerfarande foer utnyttjande i samband med tillslutandet av en vaetskefoerpackning
FI943432A0 (fi) Tillverkning av plastroerelement foersett med loesmuffoerbandsmedel
FI3524U1 (fi) Yhdistelmäkoura
FI980484A0 (fi) Foerfarande foer blaeddring av hypertextssidor med en mobilteleapparat
UA25486A (uk) Мехаhізм архімедової спіралі
DK82798A (da) Treatment of GABA-uptake related disorders